lifespan / research-brief
Yamanaka Factors at Scale: The Race to Reprogram Aging
Partial cellular reprogramming has reversed aging in mice. Now the hard work begins: making it safe for humans.
Dr. James Liu · 10 min read
lifespan / news
Altos Labs One Year Later: Progress and Promises
The world's best-funded longevity company has been notably quiet. Here's what we know about what they're building.
Marcus Webb · 8 min read
business / news
Longevity Biotech Sees Record Funding in Early 2024
Investment in aging research companies surges as institutional investors bet big on healthspan extension technologies.
Editorial Team · 6 min read
business / analysis
10 Longevity Startups to Watch in 2024
From cellular reprogramming to AI-powered drug discovery, these companies are pushing the boundaries of aging research.
Sarah Chen · 8 min read